Mandate

Vinge’s Forensic, Risk & Compliance Group assists Tele2

Tele2 has decided to leave Kazakhstan and has today published the terms and conditions governing the transaction.

In connection with the exit, Tele2 has issued the extensive report "Tele2 Kazakhstan - Exit Report on Ethics and Compliance". The Exit Report is part of Tele2’s obligation to act ethically, to fight corruption and be transparent to shareholders and the market. 
 
Vinge’s Forensic, Risk & Compliance Group has assisted Tele2 in conjunction with the company’s analysis and reporting of the anti‑corruption work which Tele2 has conducted since it arrived in Kazakhstan. In the Exit Report, Tele2 describes its method of identifying and addressing corruption risks. This method is based on Vinge’s formulated best practice – a compliance programme consisting of 10 steps which companies and organizations should implement in order to prevent bribery and corruption in their business operations. 

“It is very satisfying to work with a company which takes the risks of corruption seriously. It is not possible to prevent everything, although you can establish a framework and procedures which minimize the risk significantly”,

says Mia Falk, Head of Forensic, Risk & Compliance at Vinge.

For more information, please see Tele2’s press release as well as Tele2 Kazakhstan - Exit Report on Ethics and Compliance

Vinge’s team consisted of Mia Falk and Hayaat Ibrahim.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025